Professional Documents
Culture Documents
Systematix Sees 37% UPSIDE in Elin Electronics New Product Launches
Systematix Sees 37% UPSIDE in Elin Electronics New Product Launches
Institutional Equities
Apr-23
Mar-23
Dec-22
Aug-23
May-23
Jun-23
Investors are advised to refer disclosures made at the end of the research report.
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 1
10 August 2023 Elin Electronics
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 2
10 August 2023 Elin Electronics
• Expect growth to pick up in hair dryers and hair straighteners in coming quarters
FHP: Rev down 10% YoY, up 17% QoQ
• Volume flat YoY; QoQ up 17% in mixer grinders and 42% in chimney motors
• Motors for fans impacted on lower offtake of fans due to unseasonal rains and
cooler weather conditions
• Plans manufacturing of AC ODU and Chimney soon
WC cycle: Normal range 60-70 days
• Inventory buildup ahead of festive season led to rise in WC days in 1Q (76 days)
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 3
10 August 2023 Elin Electronics
Exhibit 1: Elin Electronics (Consolidated) – Quarterly results
(Rs mn) 1QFY23 2QFY23 3QFY23 4QFY23 1QFY24 YoY (%) QoQ (%)
Total Income 2,941 3,103 2,023 2,687 2,538 (14) (6)
Raw material costs 2,247 2,266 1,445 2,009 1,871 (17) (7)
Employee costs 356 320 276 342 348 (2) 2
Other expenses 226 204 169 248 221 (2) (11)
EBITDA 112 313 132 88 98 (12) 11
Depreciation 43 41 44 59 48 13 (17)
Finance costs 33 41 31 25 27 (17) 8
Other income 2 1 1 18 27 1,088 49
PBT 38 232 58 23 49 29 117
Tax 7 60 13 7 12 69 73
PAT (after JV/associate) 31 172 46 16 38 21 136
EPS (Rs) 0.8 4.2 1.0 0.3 0.8 3 136
As % Total Income YoY (bps) QoQ (bps)
Gross margin 23.6 27.0 28.5 25.2 26.3 269 104
Emp cost 12.1 10.3 13.6 12.7 13.7 159 99
Other exp 7.7 6.6 8.4 9.2 8.7 104 (52)
EBITDA margin 3.8 10.1 6.5 3.3 3.9 6 57
Dep 1.5 1.3 2.2 2.2 1.9 45 (27)
Interest 1.1 1.3 1.5 0.9 1.1 (4) 13
Other income 0.1 0.0 0.1 0.7 1.1 100 39
PBT 1.3 7.5 2.9 0.8 1.9 65 110
Effective tax rate 18.0 25.9 21.7 29.5 23.5 548 (603)
PAT margin 1.1 5.5 2.3 0.6 1.5 42 89
Segment Revenues YoY (%) QoQ (%)
Lighting, Fans and Switches 1,015 873 753 909 832 (18) (8)
Small Appliances 619 872 314 700 527 (15) (25)
FHP Motor 601 535 352 464 541 (10) 17
Other EMS 101 78 75 119 93 (8) (22)
Total EMS 2,336 2,358 1,494 2,192 1,993 (15) (9)
Precision Comp. & Others 596 673 488 496 539 (10) 9
Medical Diagnostics Cartridges 9 72 41 - 6 (33) na
Total Non-EMS 605 745 529 496 545 (10) 10
Segment Mix
Lighting, Fans and Switches 35 28 37 34 33
Small Appliances 21 28 16 26 21
FHP Motor 20 17 17 17 21
Other EMS 3 3 4 4 4
Total EMS 79 76 74 82 79
Precision Comp. & Others 20 22 24 18 21
Medical Diagnostics Cartridges 0 2 2 - 0
Total Non-EMS 21 24 26 18 21
Source: Company, Systematix Institutional Research
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 4
10 August 2023 Elin Electronics
Exhibit 2: Elin - Revenue breakdown (Rs mn)
FY19 FY20 FY21 FY22 FY23 1QFY24
Lighting, Fans and Switches 3,161 2,928 2,558 3,325 3,551 831
Kitchen & Home Care 1,786 1,520 1,635 1,972 1,781 336
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 5
10 August 2023 Elin Electronics
Quarterly performance
Exhibit 3: Revenue mix trend - productwise Exhibit 4: Revenue mix trend - industrywise
100% 3 3 3 4 4 100%
3 4
24 19 20 22 24 18 21 24 19 21 24 18 21
26
75%
20 20 17 75%
22 17 17 21
50% 26
15 26 21 28 16 21
50%
25% 76 81 79 76 82 79
37 74
36 31 35 28 34 33
25%
0%
3QFY22 4QFY22 1QFY23 2QFY23 3QFY23 4QFY23 1QFY24
Lighting, Fans and Switches Small Appliances 0%
FHP Motor Precision Components & Others 3QFY22 4QFY22 1QFY23 2QFY23 3QFY23 4QFY23 1QFY24
EMS Other Non EMS
Other EMS Medical Diagnostics Cartridges
Exhibit 5: Total Income - quarterly trend Exhibit 6: Expenses as % total income - quarterly trend
(Rs mn) (%) (%)
77 76.4 13.6 13.7 15
4,000
12.7
75.0 74.7
3,170 3,103
2,941 75 10.3 74.8 73.7 11
3,000 2,687 11.9 12.1
2,585 2,538 8.4
10.8
2,023 72 73.0 9.2 8.7 8
2,000 7.7
7.0 6.6 6.6 71.5
70 4
1,000
67 0
3QFY22 4QFY22 1QFY23 2QFY23 3QFY23 4QFY23 1QFY24
0
Raw material Employee (RHS) Others (RHS)
3QFY22 4QFY22 1QFY23 2QFY23 3QFY23 4QFY23 1QFY24
Exhibit 7: EBITDA, PAT & margin trend Exhibit 8: Earnings - quarterly trend
(Rs mn) (%) (Rs)
350 14 6
10.1
263 11 4.2
5
7.9
6.2 6.5 3.2
175 7
3
3.8 3.9
3.3
88 4 1.7
161
251
129
112
313
172
132
69
2
16
38
31
46
88
98
1.0 0.8
0.8
0 0 0.3
3QFY22 4QFY22 1QFY23 2QFY23 3QFY23 4QFY23 1QFY24
0
EBITDA PAT EBITDA margin (RHS) 3QFY22 4QFY22 1QFY23 2QFY23 3QFY23 4QFY23 1QFY24
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 6
10 August 2023 Elin Electronics
Exhibit 9: Lighting, Fans and Switches - Revenue trend Exhibit 10: Small Appliances - Revenue trend
(Rs mn) (Rs mn)
1,200 938 872
1,015 834
973
921 909
873 700
900 832 704
753 619
527
600 469 399
314
300 235
0 0
3QFY22 4QFY22 1QFY23 2QFY23 3QFY23 4QFY23 1QFY24 3QFY22 4QFY22 1QFY23 2QFY23 3QFY23 4QFY23 1QFY24
Exhibit 11: FHP Motor - Revenue trend Exhibit 12: Precision Components & Others - Revenue trend
(Rs mn) (Rs mn)
700 645 800
601 673
566
535 541 609 596
590
525 464 600 539
488 496
352
350 400
175 200
0 0
3QFY22 4QFY22 1QFY23 2QFY23 3QFY23 4QFY23 1QFY24 3QFY22 4QFY22 1QFY23 2QFY23 3QFY23 4QFY23 1QFY24
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 7
10 August 2023 Elin Electronics
Annual performance
Exhibit 13: Segment-wise revenue mix
FY19 FY20 FY21 FY22 FY23 FY24E FY25E
Total revenue (Rs mn) 8,283 7,856 8,624 10,936 10,755 12,368 14,223
Revenue mix (%)
Lighting, Fans and Switches 38 37 30 30 33 33 33
Small Appliances 28 25 22 23 23 23 23
FHP Motor 12 15 21 22 18 18 18
Other EMS 2 4 3 3 3 3 3
Total EMS 80 81 77 78 78 78 78
Total Non-EMS 20 19 23 22 22 22 22
Source: Company
Exhibit 14: Revenue growth trend Exhibit 15: Gross, EBITDA and PAT margin trend
(Rs bn) (%) (%)
16 14.2
FY20-23 CAGR: 11% 35 29.5 10
12.4 27.6 25.9 26.9 27.1
FY23-25E CAGR: 15% 25.4
12 10.9 10.8 26 8
8.6 7.7 7.2 7.3 7.7
7.9 18 7.1 5
8 6.1
9 4.0 4.0 4.4 3
3.5 3.6
4 2.5
0 0
FY20 FY21 FY22 FY23 FY24E FY25E
0
Gross margin EBITDA margin (RHS) PAT margin (RHS)
FY20 FY21 FY22 FY23 FY24E FY25E
Exhibit 16: PAT growth trend Exhibit 17: NWC cycle trend
(Rs mn) (%) (Days)
FY20-23 CAGR: -1%
82
800 5 90
77
66
66
67
66
66
59
600 4.4 4 68
49
48
4.0 4.0
43
43
44
42
42
43
42
42
40
3.6
37
400 3.5 3 45 33
32
2.5
200 1 23
275 348 391 269 495 628
0 0 0
FY20 FY21 FY22 FY23 FY24E FY25E Debtor Days Inventory Days Creditor Days Net-WC Days
PAT PAT margin (RHS) FY20 FY21 FY22 FY23 FY24E FY25E
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 8
10 August 2023 Elin Electronics
Key Risks
• Demand slowdown in the key product categories
• Volatility in RM prices
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 9
10 August 2023 Elin Electronics
FINANCIALS (CONSOLIDATED)
Profit & Loss Statement Balance Sheet
YE: Mar (Rs mn) FY21 FY22 FY23 FY24E FY25E YE: Mar (Rs mn) FY21 FY22 FY23 FY24E FY25E
Net revenues 8,624 10,938 10,755 12,368 14,223 Share capital 68 204 240 240 240
Growth (%) 10 27 (2) 15 15 Net worth 2,623 3,031 4,931 5,378 5,959
Direct costs 6,247 8,157 7,967 9,039 10,366 Total debt 1,140 1,025 784 714 644
Gross Margin (%) 27.6 25.4 25.9 26.9 27.1 Minority interest - - - - -
SG&A 1,712 1,991 2,136 2,432 2,768 DT Liability/(Asset) 78 92 104 114 124
EBITDA 665 790 652 898 1,090 Capital Employed 3,840 4,149 5,818 6,205 6,726
EBITDA margins (%) 7.7 7.2 6.1 7.3 7.7 Net tangible assets 1,606 1,876 2,313 2,449 2,552
- Depreciation 118 144 186 214 246 Net Intangible assets 7 4 11 11 11
Other income 25 9 23 49 57 Goodwill - - - - -
Interest Exp 97 127 131 74 64 CWIP 1 0 1 1 1
PBT 475 529 358 659 836 Investments (Strategic) - - - - -
Effective tax rate (%) 26.6 26.0 24.9 24.9 24.9 Investments (Financial) 136 12 265 465 665
+ Associates/(Minorities) - - - - - Current Assets 3,280 3,385 3,755 4,306 4,930
Net Income 348 391 269 495 628 Cash 54 49 997 718 561
Adjusted income 348 391 269 495 628 Current Liabilities 1,243 1,178 1,524 1,745 1,995
WANS 14 41 48 48 48 Working capital 2,037 2,207 2,231 2,561 2,935
FDEPS (Rs) 7 8 6 10 13 Capital Deployed 3,840 4,149 5,818 6,205 6,726
FDEPS growth (%) 27 12 (31) 84 27 Contingent Liabilities 74 89 - - -
Source: Company, Systematix Institutional Research Source: Company, Systematix Institutional Research
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 10
10 August 2023 Elin Electronics
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 11
10 August 2023 Elin Electronics
DISCLOSURES/APPENDIX
I. ANALYST CERTIFICATION
I, Ashish Poddar, Pranay Shah, Shraddha Kapadia; hereby certify that (1) views expressed in this research report accurately reflect my/our personal views about any or all of the subject
securities or issuers referred to in this research report, (2) no part of my/our compensation was, is, or will be directly or indirectly related to the specific recommendations or views
expressed in this research report by Systematix Shares and Stocks (India) Limited (SSSIL) or its group/associate companies, (3) reasonable care is taken to achieve and maintain
independence and objectivity in making any recommendations.
II. ISSUER SPECIFIC REGULATORY DISCLOSURES, unless specifically mentioned in point no. 9 below:
1. The research analyst(s), SSSIL, associates or relatives do not have any financial interest in the company(ies) covered in this report.
2. The research analyst(s), SSSIL, associates or relatives collectively do not hold more than 1% of the securities of the company(ies) covered in this report as of the end of the
month immediately preceding the distribution of the research report.
3. The research analyst(s), SSSIL, associates or relatives did not have any other material conflict of interest at the time of publication of this research report.
4. The research analyst, SSSIL and its associates have not received compensation for investment banking or merchant banking or brokerage services or any other products or
services from the company(ies) covered in this report in the past twelve months.
5. The research analyst, SSSIL or its associates have not managed or co-managed a private or public offering of securities for the company(ies) covered in this report in the previous
twelve months.
6. SSSIL or its associates have not received compensation or other benefits from the company(ies) covered in this report or from any third party in connection with this research
report.
7. The research analyst has not served as an officer, director or employee of the company(ies) covered in this research report.
8. The research analyst and SSSIL have not been engaged in market making activity for the company(ies) covered in this research report.
9. Details of SSSIL, research analyst and its associates pertaining to the companies covered in this research report:
Sr. Yes /
Particulars
No. No.
1 Whether compensation was received from the company(ies) covered in the research report in the past 12 months for investment banking transaction by SSSIL. No
2 Whether research analyst, SSSIL or its associates and relatives collectively hold more than 1% of the company(ies) covered in the research report. No
3 Whether compensation has been received by SSSIL or its associates from the company(ies) covered in the research report. No
Whether SSSIL or its affiliates have managed or co-managed a private or public offering of securities for the company(ies) covered in the research report in the
4 No
previous twelve months.
Whether research analyst, SSSIL or associates have received compensation for investment banking or merchant banking or brokerage services or any other
5 No
products or services from the company(ies) covered in the research report in the last twelve months.
10. There is no material disciplinary action taken by any regulatory authority that impacts the equity research analysis activities.
STOCK RATINGS
BUY (B): The stock's total return is expected to exceed 15% over the next 12 months.
HOLD (H): The stock's total return is expected to be within -15% to +15% over the next 12 months.
SELL (S): The stock's total return is expected to give negative returns of more than 15% over the next 12 months.
NOT RATED (NR): The analyst has no recommendation on the stock under review.
INDUSTRY VIEWS
ATTRACTIVE (AT): Fundamentals/valuations of the sector are expected to be attractive over the next 12-18 months.
NEUTRAL (NL): Fundamentals/valuations of the sector are expected to neither improve nor deteriorate over the next 12-18 months.
CAUTIOUS (CS): Fundamentals/valuations of the sector are expected to deteriorate over the next 12-18 months.
III. DISCLAIMER
The information and opinions contained herein have been compiled or arrived at based on the information obtained in good faith from sources believed to be reliable. Such information
has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy completeness or correctness.
This document is for information purposes only. This report is based on information that we consider reliable; we do not represent that it is accurate or complete and one should exercise
due caution while acting on it. Description of any company(ies) or its/their securities mentioned herein are not complete and this document is not and should not be construed as an
offer or solicitation of an offer to buy or sell any securities or other financial instruments. Past performance is not a guide for future performance, future returns are not guaranteed and
a loss of original capital may occur. All opinions, projections and estimates constitute the judgment of the author as on the date of the report and these, plus any other information
contained in the report, are subject to change without notice. Prices and availability of financial instruments are also subject to change without notice. This report is intended for
distribution to institutional investors.
This report is not directed to or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity that is a citizen or resident or located in any
locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject to SSSIL or
its affiliates to any registration or licensing requirement within such jurisdiction. If this report is inadvertently sent or has reached any individual in such country, especially USA, the same
may be ignored and brought to the attention of the sender. Neither this document nor any copy of it may be taken or transmitted into the United States (to U.S. persons), Canada, or
Japan or distributed, directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. Any unauthorized use, duplication,
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 12
10 August 2023 Elin Electronics
redistribution or disclosure of this report including, but not limited to, redistribution by electronic mail, posting of the report on a website or page, and/or providing to a third party a link,
is prohibited by law and will result in prosecution. The information contained in the report is intended solely for the recipient and may not be further distributed by the recipient to any
third party.
SSSIL generally prohibits its analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any
companies that the analysts cover. Additionally, SSSIL generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or advisory board member of
any companies that they cover. Our salespeople, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that
reflect opinions that are contrary to the opinions expressed herein. Our proprietary trading and investing businesses may make investment decisions that are inconsistent with the
recommendations expressed herein. The views expressed in this research report reflect the personal views of the analyst(s) about the subject securities or issues and no part of the
compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The
compensation of the analyst who prepared this document is determined exclusively by SSSIL; however, compensation may relate to the revenues of the Systematix Group as a whole, of
which investment banking, sales and trading are a part. Research analysts and sales persons of SSSIL may provide important inputs to its affiliated company(ies).
Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations which could have an adverse effect on their value or price or the income
derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies, effectively assume currency risk. SSSIL, its directors, analysts
or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on the basis of this report
including but not restricted to fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc.
SSSIL and its affiliates, officers, directors, and employees subject to the information given in the disclosures may: (a) from time to time, have long or short positions in, and buy or sell, the
securities thereof, of company (ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation (financial interest)
or act as a market maker in the financial instruments of the company (ies) discussed herein or act as advisor or lender / borrower to such company (ies) or have other potential material
conflict of interest with respect to any recommendation and related information and opinions. The views expressed are those of the analyst and the company may or may not subscribe
to the views expressed therein.
SSSIL, its affiliates and any third party involved in, or related to, computing or compiling the information hereby expressly disclaim all warranties of originality, accuracy, completeness,
merchantability or fitness for a particular purpose with respect to any of this information. Without limiting any of the foregoing, in no event shall SSSIL, any of its affiliates or any third
party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. The company accepts no liability whatsoever for the actions of
third parties. The report may provide the addresses of, or contain hyperlinks to, websites. Except to the extent to which the report refers to website material of the company, the
company has not reviewed the linked site. Accessing such website or following such link through the report or the website of the company shall be at your own risk and the company
shall have no liability arising out of, or in connection with, any such referenced website.
SSSIL will not be liable for any delay or any other interruption which may occur in presenting the data due to any technical glitch to present the data. In no event shall SSSIL be liable for
any damages, including without limitation, direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with the data presented by SSSIL
through this presentation.
SSSIL or any of its other group companies or associates will not be responsible for any decisions taken on the basis of this report. Investors are advised to consult their investment
and tax consultants before taking any investment decisions based on this report.
Systematix Research is also available on Bloomberg SSSL <Go>, Thomson & Reuters Systematix Shares and Stocks (India) Limited 13